Transforming global health with purposeful innovation
About us
Our commitment to Global Health
Medincell’s core mission is to enhance and safeguard the health of people worldwide. We believe in the equitable distribution of the value we create, ensuring all our employees are recognized and rewarded. This principle underpins our business model and is crucial to Medincell’s enduring success, enabling us to steadfastly pursue our goals.
Addressing Global Health challenges, how do we make a difference?
Improving treatment adherence
According to the World Health Organization, half of all patients either don’t initiate or discontinue their prescribed treatments. Enhancing adherence is pivotal and could surpass any medical advancements in treatment. By focusing on this aspect, we aim to transform patient outcomes significantly.
Enhancing treatment accessibility
Our cutting-edge technologies, when combined with our inclusive “Global Access” initiative, are designed to provide equitable treatment options for individuals around the world, irrespective of their financial means or healthcare systems.
Minimizing environmental impact
We are committed to reducing pharmaceutical residues, a pressing ecological concern. Our technologies strive to minimize the active ingredients required for treatments and prevent pharmaceutical waste from bypassing recycling processes.
Our approach to realizing our vision
Patient-centric collaboration
Collaboration is the essence of our approach. To offer novel therapeutic solutions globally, we’ve cultivated a network of esteemed partners, encompassing industry experts, academic researchers, and leading foundations.
Value sharing
We advocate for employee share ownership, promoting the equitable distribution of generated value. This fosters a harmonious dynamic between our management and staff, aligning the interests of all stakeholders — employees, shareholders, and partners alike.
Diversity and workplace well-being
Our strength lies in our diverse and gifted team. We are dedicated to maintaining a nurturing and respectful work environment, as the well-being of our team is a top priority.
Our strength lies in our people
Since Medincell’s inception, the expertise and dedicated engagement of our team have been vital to our growth. To share our achievements and maintain our collective aspiration of ‘positively impacting health,’ we ensure that all employees become shareholders shortly after joining us. This practice of involving all collaborators early in our success has fostered an entrepreneurial spirit across every level of the organization.
Medincell in one word
Join the team
Unleash your entrepreneurial spirit within a creative and innovative team of international experts dedicated to tackling global health challenges.
Leadership team
Our commitment transcends our core objectives, it is a pledge to serve not only patients worldwide but also to support our dedicated team and to align the interests of all Medincell stakeholders.
Management team
Christophe Douat
Richard Malamut, MD
Sébastien Enault
Julie Alimi
David Heuzé
Stéphane Chambaud
Stéphane Postic
Franck Pouzache
Adolfo Lopez-Noriega
Helen Martin
Quiterie de Beauregard
Supervisory board
Philippe Guy is engaged on a pro-bono basis with the Foundation de la Mer, where his efforts are focused on scaling up its international impact. This includes contributing to key United Nations negotiations and facilitating the formation of coalitions among like-minded European foundations.
Besides MedinCell, Philippe also serves on the Board of Moleac, a Singapore-based company helping patients with brain injuries and neurological conditions.
Philippe Guy multifaceted career trajectory reflects a blend of strategic leadership in healthcare and a deep-seated commitment to ESG.